A pharmaceutical drug conceptualized by artificial intelligence will be tested on 60 people. The drug, which will treat chronic lung disease, is under development by Insilico Medicine and has already completed successful phase 1 trials.

We’ve curated insightful analysis on how generative AI is being used to make drugs more efficiently than traditional methods.


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *